LAM
PFE icon

Lummis Asset Management’s Pfizer PFE Stock Holding History

Lummis Asset Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$302K Hold
11,314
– – 0.18% 53
2025
Q4 		$282K Hold
11,314
– – 0.17% 52
2025
Q3 		$288K Hold
11,314
– – 0.19% 53
2025
Q2 		$278K Hold
11,314
– – 0.18% 54
2025
Q1 		$276K Buy
+11,314
New +$296K 0.19% 52
2024
Q1 		– Sell
-11,314
Closed -$326K – 175
2023
Q4 		$326K Buy
+11,314
New +$342K 0.25% 50

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Lummis Asset Management's PFE Position: Q1 2026 in Review

Lummis Asset Management held its Pfizer (PFE) position steady in Q1 2026 at 11,314 shares worth $302K. The position accounts for 0.18% of the portfolio, ranked #53.

Lummis Asset Management first reported a position in PFE in Q4 2023 and has held it in 6 quarters since. The position peaked at $326K in Q4 2023. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Lummis Asset Management held 11,314 shares of Pfizer worth $302K as of Q1 2026.
  • Lummis Asset Management left its Pfizer share count unchanged in Q1 2026.
  • Pfizer made up 0.18% of Lummis Asset Management's portfolio in Q1 2026, its #53 holding.
  • Lummis Asset Management first reported a position in Pfizer in Q4 2023 and has held it in 6 quarters since.
  • Lummis Asset Management's Pfizer position peaked at $326K in Q4 2023.
  • 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Lummis Asset Management's 13F filing for Q1 2026, filed 11 May 2026.